With 35+ years of oncology innovation, With Patient first approach
“Our Promise: Quality Across Continents”
Wembrace Biopharma is an India-based pharmaceutical company focused on oncology related products manufacturing and marketing. Our portfolio spans innovative therapies, conventional oncology, supportive care, and onco-cosmeceuticals.
We work with hospitals, procurement teams, and channel partners to deliver high-quality pharmaceutical solutions supported by strong regulatory adherence and pharmacovigilance awareness.
Reliable access to oncology and supportive care products backed by quality systems and strategic commercial assistance.
Comprehensive institutional supply support with a strong emphasis on regulatory compliance, documentation discipline, consistency, and execution excellence.
A globally compliant, export-ready portfolio backed by robust regulatory, documentation, and supply capabilities.
Speak to Our Team →
Abiraterone Acetate Dispersible
Protein Powder
Cream with 20% UREA + PENTAVIYIN
Doctaxel Lipid Suspension for Injection 20mg/vial
Paclitaxel (protein-bound particle) for Injectable Suspension 100mg/vial
Megestrol Acetate Tablets
Palbociclib Capsules
Carboplatin Injection 450mg
Ifosfamide Injection 1gm
Glutathione Injection 1200mg
Piperacilin & Tazobactam Injection 4.5gm
Teicoplanin Injection 200mg
Meropenem & Tazobactam Injection 1.125 gm
Resveratrol & L-Glutathione Tablets
Hydrocortisone Sodium Succinate Injection 100mg
Abiraterone Acetate Dispersible
Protein Powder
Cream with 20% UREA + PENTAVIYIN
Doctaxel Lipid Suspension for Injection 20mg/vial
Paclitaxel (protein-bound particle) for Injectable Suspension 100mg/vial
Megestrol Acetate Tablets
Palbociclib Capsules
Carboplatin Injection 450mg
Ifosfamide Injection 1gm
Glutathione Injection 1200mg
Piperacillin & Tazobactam Injection 4.5gm
Teicoplanin Injection 200mg
Meropenem & Tazobactam Injection 1.125 gm
Resveratrol & L-Glutathione Tablets
Hydrocortisone Sodium Succinate Injection 100mg
Our manufacturing facilities follow WHO-GMP compliant processes, ensuring strict quality control, product safety, and regulatory standards across all oncology formulations.
We specialize in oncology and supportive care formulations, combining scientific research with advanced pharmaceutical development to support modern cancer treatment.
All products are developed and manufactured in accordance with international regulatory guidelines, ensuring reliability, safety, and consistent product performance.
Wembrace supports international distributors and healthcare institutions with dependable supply capabilities, enabling seamless access to high-quality pharmaceutical products.
Wembrace offers an integrated portfolio addressing cancer treatment, supportive care, and patient well-being across the healthcare continuum.
Transformational oncology solutions tailored to meet the demands of modern clinical practice and emerging treatment strategies
Explore Innovative Oncology
Scientifically developed formulations to support dermal health and adds omfort throughout oncology treatment.
Explore Onco-Cosmeceuticals
Well-established cancer treatments that are built to support structured institutional and clinical treatment requirements.
Explore Conventional Oncology
Clinically driven solutions focused on mitigating treatment-related side effects and enhancing patient recovery outcomes.
Explore Supportive Care
At Wembrace, we deliver oncology products and healthcare solutions tailored to the evolving needs of healthcare institutions and global partners. Our commitment to quality systems, scientific excellence, and supply reliability for sustainable, long-term collaborations
Our manufacturing operations are guided by structured processes, delivering dependable oncology formulations backed by robust quality control systems
Clinical, scientific, and educational content on oncology, supportive care, and healthcare trends.
Table of Contents Whey protein has emerged as a clinically relevant nutritional solution in supportive cancer care. Evidence highlights whey protein as a complete, rapidly
Cancer’s global footprint keeps growing; ageing populations and changing exposures (tobacco, obesity, pollution) are driving a projected rise in new cases and deaths over the
Lung cancer is one of the most common malignant cancers in most countries and is the leading cause of death among cancer diseases worldwide.1 The
Pancreatic cancer remains one of the most formidable malignancies: relatively rare compared to others, yet disproportionately deadly. In this blog, we’ll explore key facts about
